会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明公开
    • 코로나바이러스에 대한 항바이러스 활성을 가지는코르디세핀
    • CORDYCEPIN显示对CORONAVIRUS的抗病毒效果
    • KR1020060125047A
    • 2006-12-06
    • KR1020050046832
    • 2005-06-01
    • 한국생명공학연구원
    • 이충환권두한오태광김진희지상천최화정
    • A61K31/7076
    • A61K31/7076
    • A material, cordycepin, showing the antiviral effect against coronavirus is provided to treat diseases caused by coronavirus with reduced toxicity and side effects. The material, cordycepin, showing the antiviral effect against coronavirus, represented by the formula(1) is provided, wherein the cordycepin is isolated from Paecilomyces japonica or chemically synthesized by conventional organic synthesis. An antiviral composition comprises the cordycepin or its pharmaceutically acceptable salt as an effective ingredient, wherein the coronavirus is porcine coronavirus, canine coronavirus, bovine coronavirus or SARS(severe acute respiratory syndrome) virus; the dosage of the effective ingredient is 1-50mg/kg per day; and the composition is formulated as tablet, troches, lozenge, water-soluble or oily suspension, powder, granule, emulsion, hard or soft capsule, syrup or elixirs.
    • 提供一种显示抗冠状病毒抗病毒作用的材料,虫草素用于治疗由冠状病毒引起的疾病,毒性和副作用降低。 提供了由式(1)表示的对冠状病毒的抗病毒作用的材料,虫草素,其中冬虫夏草从拟青藓分离,或通过常规的有机合成化学合成。 抗病毒组合物包含虫草素或其药学上可接受的盐作为有效成分,其中冠状病毒是猪冠状病毒,犬冠状病毒,牛冠状病毒或SARS(严重急性呼吸综合征)病毒; 有效成分的剂量为每天1-50mg / kg; 并且组合物配制成片剂,锭剂,锭剂,水溶性或油性悬浮液,粉末,颗粒,乳液,硬或软胶囊,糖浆或酏剂。